Learn how leading manufacturers are connecting manufacturing, quality, and supply chain systems to improve visibility, accelerate decision making and create more agile operations. The session will explore how organizations are strengthening supply chains and preparing their workforce for increasingly digital manufacturing environments.
Returning to Boston this March Connect with Fellow Leaders Shaping Cell and Gene Therapy Development The eighth in a series of premier one-day events held in the world's biggest biotech hubs, Charles River is bringing together the leading experts, executives, and thought leaders in the CGT space to discuss and navigate critical challenges. Register today to...
As biologics grow more complex and development timelines continue to tighten, many teams could encounter manufacturability challenges related to decisions around media, process, and scalability made earlier in development. Traditional, sequential workflows may not always surface potential challenges until programs are already moving toward scale-up, which can limit flexibility. In this webinar, Thermo Fisher Scientific...
AI is reshaping every industry—and drug discovery is no exception. Across targets, molecules, and data at massive scale, AI is becoming integral to how modern therapeutics are discovered and developed. This panel explores how foundational open‑source AI engines like OpenFold and Boltz are being used across the drug discovery workflow, from target discovery and validation...
In today’s fast-paced biopharma and CDMO environments, single-use assembly design is about confidence in quality, supply continuity, and process performance. This webinar explores how Thermo Scientific™ Single-Use Assemblies are designed to help reduce risk, support flexible manufacturing, and help organizations meet production milestones and maintain momentum when time to market is crucial. Attendees will see...
Phase 2 neurodegenerative trials are increasingly challenged by slow disease trajectories, heterogeneous patient populations, and blunt legacy endpoints that struggle to detect treatment-related change over typical study durations. Traditional scales such as ADAS-Cog and MDS-UPDRS, while well-established, often lack sensitivity in early disease, are vulnerable to rater and practice effects, and may insufficiently capture subtle...
The Cell & Gene Tech Expo is designed to aid professionals in discovering the latest advancements and equipment critical to cell and gene therapy development. Attendees will explore state-of-the-art solutions such as bioreactor systems, cell sorting and isolation technologies, automated platforms, non-viral gene editing tools like electroporation and CRISPR, data monitoring tools, sterilization solutions, and...
The life sciences and biotech community navigated a historically challenging landscape in 2025. Between shifts in federal agency structures and financial hurdles on Wall Street, the industry faced significant uncertainty. However, innovation has not slowed down. From CRISPR gene-editing breakthroughs to AI-bolstered drug discovery and advances in materials science, the potential for progress remains stronger...
The Life Sciences Future SW conference will unite stakeholders from the region and beyond, including life sciences start-ups, established industry leaders, academic institutions, healthcare providers, and investors. This event will strengthen connections with the Southwest region while fostering new relationships across the state. The conference aims to create a more cohesive and thriving regional ecosystem that supports...
Microbial systems are foundational to plasmid DNA and recombinant protein production, yet scaling from development to production often introduces variability, performance limitations, and regulatory complexity—especially when complex media components are involved. As organizations push for higher yields, improved reproducibility, and animal origin free workflows, chemically defined solutions are becoming essential. In this webinar, Stanislav Pepeliaev...
